U.S. markets open in 1 hour 26 minutes

ALX Oncology Holdings Inc. (ALXO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
58.22+1.86 (+3.30%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/26/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 373.63%
S&P500 52-Week Change 335.59%
52 Week High 3117.45
52 Week Low 330.06
50-Day Moving Average 356.86
200-Day Moving Average 366.85

Share Statistics

Avg Vol (3 month) 3219.55k
Avg Vol (10 day) 3284.61k
Shares Outstanding 540.23M
Implied Shares Outstanding 6N/A
Float 17.21M
% Held by Insiders 114.40%
% Held by Institutions 184.12%
Shares Short (Jul 14, 2021) 42.08M
Short Ratio (Jul 14, 2021) 48.45
Short % of Float (Jul 14, 2021) 411.97%
Short % of Shares Outstanding (Jul 14, 2021) 45.16%
Shares Short (prior month Jun 14, 2021) 42.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-9,986.53%

Management Effectiveness

Return on Assets (ttm)-12.15%
Return on Equity (ttm)-21.05%

Income Statement

Revenue (ttm)527k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)107k
EBITDA -52.53M
Net Income Avi to Common (ttm)-57.69M
Diluted EPS (ttm)-2.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)429.86M
Total Cash Per Share (mrq)10.69
Total Debt (mrq)532k
Total Debt/Equity (mrq)0.13
Current Ratio (mrq)30.60
Book Value Per Share (mrq)10.41

Cash Flow Statement

Operating Cash Flow (ttm)-34.46M
Levered Free Cash Flow (ttm)-15.14M